Increased GABA-gated chloride ion influx in the hypothalamus of low-anxiety rats

Physiology and Behavior

Volumn 64, Issue 3, 1998, Pages 415-417

  Imamura, Makoto ^a   Prasad, Chandan ^a  

^a Obesity Research Program   (United States)

Author keywords

Anxiety; Chloride influx; Depression; Hypothalamus

Indexed keywords

4 AMINOBUTYRIC ACID;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CHLORIDE TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEPRESSION; HYPOTHALAMUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032096538     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-9384(98)00105-X     Document Type: Article

References (18)

1. Altemus M., Smith M.A., Diep V., Aulakh C.S., Murphy D.L. Increased mRNA for corticotropin-releasing hormone in the amygdala of fawn-hooded rats: A potential animal model of anxiety. Anxiety. 1:1994;251-257.
2. Dunn A.J., Berridge C.W. Physiological and behavioral responses to corticotropin-releasing factor administration: Is CRF a mediator of anxiety and stress responses? Brain Res. Rev. 15:1990;71-100.
3. Franciolini F., Petris A. Chloride channels in biological membranes. Biochim. Biophys. Acta. 1031:1990;247-259.
4. Francis J., Mihic S.J., Sneddon W.B., Burnham W.M. The effect of anticonvulsant drugs on GABA-stimulated chloride uptake. Can. J. Neurol. Sci. 21:1994;3-8.
5. Glowinski J., Iversen L.L. Regional studies of catecholamines in the rat brain. J. Neurochem. 13:1966;655-664.
6. Holsboer F., Spengler D., Heuser I. The role of corticotropin-releasing hormone in the pathogenesis of Cushing's disease, anorexia nervosa, alcoholism, affective disorders and dementia. Prog. Brain Res. 93:1992;385-417.
7. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
8. Malatynska E., DeLeon I., Allen E., Yamamura H.I. Effects of amitriptyline on GABA-stimulated 36CI-uptake in relation to a behavioral model of depression. Brain Res. Bull. 37:1995;53-59.
9. Pellow S., Chopin P., File S.E., Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods. 14:1985;149-167.
10. Picazo O., Fernandez-Guasti A. Anti-anxiety effects of progesterone and some of its reduced metabolites: An evaluation using the burying behavior test. Brain Research. 680:1995;135-141.
11. Prasad A., Henry M., Prasad C. Heterogeneity in the performance of outbred Sprague-Dawley rats in an elevated-plus maze test: A possible animal model for anxiety disorder. Life Sci. 59:1996;1499-1506.
12. Prasad A., Prasad C. Short-term consumption of a diet rich in fat decreases anxiety response in adult male rats. Physiol. Behav. 60:1996;1039-1042.
13. Rivier C.L., Plotsky P.M. Mediation by corticotropin-releasing factor (CRF) of adenohypophyseal hormone secretion. Ann. Rev. Physiol. 48:1986;475-494.
14. Roberts E., Chase T.N., Tower B.D. GABA in nervous system function. 1976;Raven Press, New York.
15. Shekhar A. GABA receptors in the region of dorsomedial hypothalamus of rats regulate anxiety in the elevated plus-maze test. I. Behavioral measures. Brain Res. 627:1993;9-16.
16. Shekhar A., Hingtgen J.N., DiMicco J.A. GABA receptors in the posterior hypothalamus regulate experimental anxiety. Brain Res. 512:1990;81-88.
17. Wolkowitz O.M., Reus V.I., Roberts E., Manfredi F., Chan T., Ormiston S., Johnson R., Canick J., Brizendine L., Weingartner H. Antidepressant and cognition-enhancing effects of DHEA in major depression. Ann. NY Acad. Sci. 774:1995;337-339.
18. Young J., Corpechot C., Perche F., Eychenne B., Haug M., Baulieu E.E., Robel P. Neurosteroids in the mouse brain behavioral and pharmacological effects of a 3 β-hydroxysteroid dehydrogenase inhibitor . Steroids. 61:1996;144-149.